ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Clin Pharmacol Biopharm 2023, Vol 12(8): 363
  • DOI: 10.4172/2167-065X.1000363

Pharmaceutical Immunology, Highlighting Their Potential Impact on Patient Care

Brian Berge*
Department of Otolaryngology, Auburn University, U.S.A
*Corresponding Author : Brian Berge, Department of Otolaryngology, Auburn University, U.S.A, Email: brian.ber119@gmail.com

Received Date: Aug 01, 2023 / Published Date: Aug 30, 2023

Abstract

Pharmaceutical immunology has witnessed remarkable advancements in recent years, revolutionizing the treatment landscape for various diseases. This article explores some of the groundbreaking developments in immunotherapy and the ways in which these innovative approaches are reshaping the field of medicine. From checkpoint inhibitors to personalized vaccines, these advancements are unlocking the full potential of the immune system to combat diseases like cancer, autoimmune disorders, and infectious diseases.

Citation: Berge B (2023) Pharmaceutical Immunology, Highlighting Their PotentialImpact on Patient Care. Clin Pharmacol Biopharm, 12: 363. Doi: 10.4172/2167-065X.1000363

Copyright: © 2023 Berge B. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top